## Abstract ## Objective To measure rates of decline in cognition and function in patients with Alzheimer's disease (AD) and to investigate their accelerating risk factors in Korea. ## Methods This study presents longitudinal data on a community‐based sample of 107 patients with AD, followed at
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
✍ Scribed by Victor L. Villemagne; Kerryn E. Pike; Gaël Chételat; Kathryn A. Ellis; Rachel S. Mulligan; Pierrick Bourgeat; Uwe Ackermann; Gareth Jones; Cassandra Szoeke; Olivier Salvado; Ralph Martins; Graeme O'Keefe; Chester A. Mathis; William E. Klunk; David Ames; Colin L. Masters; Christopher C. Rowe
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 825 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
This paper reviews data on the natural history of symptoms in patients with Alzheimer's disease (AD) and describes some of the problems encountered in analysing longitudinal data in this population. Data on cognition, functional ability and psychiatric or behavioural symptoms have all been obtained
## Abstract ## Background Stroke risk factors have been increasingly implicated in the development of age‐related cognitive decline, the spectrum of vascular cognitive impairment, and, more recently, Alzheimer's disease (AD). In addition, depression and the apolipoprotein (APOE) ε4 allele have bee
Cerebral cholinergic deficits have been described in Alzheimer disease (AD) and as a result of normal aging. At the present time, there are very limited options for the quantification of cholinergic receptors with in vivo imaging techniques such as PET. In the present study, we examined the feasibil